The formation of the PTPRO/EGFR complex inhibits Tyr845 phosphorylation in EGFR by directly dephosphorylating Src at Tyr416, which inhibits the progression and drug resistance of CRC cells [100]. Here, EGFR is linked to colorectal carcinoma.